P139 OLORINAB, A PERIPHERALLY RESTRICTED, HIGHLY SELECTIVE AGONIST OF THE CANNABINOID RECEPTOR TYPE 2 FOR THE MANAGEMENT OF VISCERAL PAIN IN INFLAMMATORY BOWEL DISEASE (IBD) – PRECLINICAL AND EARLY CLINICAL DEVELOPMENT

Abstract Introduction Abdominal pain is common and persistent in patients with IBD. Available anti-inflammatory treatments often fail to relieve pain despite disease remission. Cannabinoid receptor agonists have shown efficacy in visceral pain, but development has been limited by psychotropic effect...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Inflammatory bowel diseases 2019-02, Vol.25 (Supplement_1), p.S64-S64
Hauptverfasser:	Lindstrom, Beatriz F, Ruckle, Jon L, Turner, Stewart A, Stauber, Kathe, Brierley, Stuart M, English, Brett A, Yacyshyn, Bruce
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!